Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-022575
Filing Date
2018-08-16
Accepted
2018-08-16 17:00:48
Documents
1
Period of Report
2018-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6196
  Complete submission text file 0000899243-18-022575.txt   7682
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 324 S. HYDE PARK AVENUE STE 350 TAMPA FL 33606
Business Address
Watson W. Mark (Reporting) CIK: 0001612372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 181023865